Drug Shortage Report for VIOKACE
Report ID | 87801 |
Drug Identification Number | 02230019 |
Brand name | VIOKACE |
Common or Proper name | Viokace 10440 |
Company Name | NESTLE ENTERPRISES S.A. |
Market Status | MARKETED |
Active Ingredient(s) | AMYLASE PROTEASE LIPASE |
Strength(s) | 56400UNIT 57100UNIT 10440UNIT |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100's bottle |
ATC code | A09AA |
ATC description | DIGESTIVES, INCL ENZYMES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2019-07-12 |
Actual start date | 2019-07-12 |
Estimated end date | 2019-08-16 |
Actual end date | 2019-08-12 |
Shortage status | Resolved |
Updated date | 2019-08-13 |
Company comments | Viokace 20880 remains in stock and available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 12, RUE ENTRE-DEUX-VILLES VEVEY, -- SWITZERLAND 1800 |
Company contact information | kfeltmate@apcipharma.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2019-08-13 | English | Compare |
v11 | 2019-08-12 | French | Compare |
v10 | 2019-08-12 | English | Compare |
v9 | 2019-08-07 | French | Compare |
v8 | 2019-08-07 | English | Compare |
v7 | 2019-07-13 | English | Compare |
v6 | 2019-07-05 | French | Compare |
v5 | 2019-07-05 | English | Compare |
v4 | 2019-06-28 | French | Compare |
v3 | 2019-06-28 | English | Compare |
v2 | 2019-06-28 | French | Compare |
v1 | 2019-06-28 | English | Compare |
Showing 1 to 12 of 12